Drill Collar
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global DNA Vaccines Market Outlook 2023
1 DNA Vaccines Market Overview
1.1 Product Overview and Scope of DNA Vaccines
1.2 DNA Vaccines Segment by Type
1.2.1 Global DNA Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 DNA Vaccines Segment by Application
1.3.1 Global DNA Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Human
1.3.3 Animal
1.4 Global DNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global DNA Vaccines Revenue 2016-2027
1.4.2 Global DNA Vaccines Sales 2016-2027
1.4.3 DNA Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 DNA Vaccines Market Competition by Manufacturers
2.1 Global DNA Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global DNA Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global DNA Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers DNA Vaccines Manufacturing Sites, Area Served, Product Type
2.5 DNA Vaccines Market Competitive Situation and Trends
2.5.1 DNA Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest DNA Vaccines Players Market Share by Revenue
2.5.3 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DNA Vaccines Retrospective Market Scenario by Region
3.1 Global DNA Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global DNA Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America DNA Vaccines Market Facts & Figures by Country
3.3.1 North America DNA Vaccines Sales by Country
3.3.2 North America DNA Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe DNA Vaccines Market Facts & Figures by Country
3.4.1 Europe DNA Vaccines Sales by Country
3.4.2 Europe DNA Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific DNA Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific DNA Vaccines Sales by Region
3.5.2 Asia Pacific DNA Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America DNA Vaccines Market Facts & Figures by Country
3.6.1 Latin America DNA Vaccines Sales by Country
3.6.2 Latin America DNA Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa DNA Vaccines Sales by Country
3.7.2 Middle East and Africa DNA Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global DNA Vaccines Historic Market Analysis by Type
4.1 Global DNA Vaccines Sales Market Share by Type (2016-2021)
4.2 Global DNA Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global DNA Vaccines Price by Type (2016-2021)
5 Global DNA Vaccines Historic Market Analysis by Application
5.1 Global DNA Vaccines Sales Market Share by Application (2016-2021)
5.2 Global DNA Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global DNA Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck DNA Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK DNA Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi DNA Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zoties DNA Vaccines Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Elanco DNA Vaccines Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Indian Immunologicals DNA Vaccines Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
7 DNA Vaccines Manufacturing Cost Analysis
7.1 DNA Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of DNA Vaccines
7.4 DNA Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 DNA Vaccines Distributors List
8.3 DNA Vaccines Customers
9 DNA Vaccines Market Dynamics
9.1 DNA Vaccines Industry Trends
9.2 DNA Vaccines Growth Drivers
9.3 DNA Vaccines Market Challenges
9.4 DNA Vaccines Market Restraints
10 Global Market Forecast
10.1 DNA Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of DNA Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of DNA Vaccines by Type (2022-2027)
10.2 DNA Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of DNA Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of DNA Vaccines by Application (2022-2027)
10.3 DNA Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of DNA Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of DNA Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global DNA Vaccines Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global DNA Vaccines Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global DNA Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers DNA Vaccines Covered in This Study
Table 5. Global DNA Vaccines Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global DNA Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global DNA Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global DNA Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market DNA Vaccines Average Price (US$/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers DNA Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers DNA Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global DNA Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global DNA Vaccines Sales by Region (2016-2021) & (K Doses)
Table 16. Global DNA Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global DNA Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America DNA Vaccines Sales by Country (2016-2021) & (K Doses)
Table 19. North America DNA Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America DNA Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America DNA Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe DNA Vaccines Sales by Country (2016-2021) & (K Doses)
Table 23. Europe DNA Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe DNA Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe DNA Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific DNA Vaccines Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific DNA Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific DNA Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific DNA Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America DNA Vaccines Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America DNA Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America DNA Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America DNA Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa DNA Vaccines Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa DNA Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa DNA Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa DNA Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global DNA Vaccines Sales (K Doses) by Type (2016-2021)
Table 39. Global DNA Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global DNA Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global DNA Vaccines Revenue Share by Type (2016-2021)
Table 42. Global DNA Vaccines Price (US$/Dose) by Type (2016-2021)
Table 43. Global DNA Vaccines Sales (K Doses) by Application (2016-2021)
Table 44. Global DNA Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global DNA Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global DNA Vaccines Revenue Share by Application (2016-2021)
Table 47. Global DNA Vaccines Price (US$/Dose) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 51. Merck DNA Vaccines Product
Table 52. Merck Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 56. GSK DNA Vaccines Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 61. Sanofi DNA Vaccines Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Zoties Corporation Information
Table 64. Zoties Description and Business Overview
Table 65. Zoties DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 66. Zoties DNA Vaccines Product
Table 67. Zoties Recent Developments/Updates
Table 68. Elanco Corporation Information
Table 69. Elanco Description and Business Overview
Table 70. Elanco DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 71. Elanco DNA Vaccines Product
Table 72. Elanco Recent Developments/Updates
Table 73. Boehringer-Ingelheim Corporation Information
Table 74. Boehringer-Ingelheim Description and Business Overview
Table 75. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 76. Boehringer-Ingelheim DNA Vaccines Product
Table 77. Boehringer-Ingelheim Recent Developments/Updates
Table 78. Indian Immunologicals Corporation Information
Table 79. Indian Immunologicals Description and Business Overview
Table 80. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 81. Indian Immunologicals DNA Vaccines Product
Table 82. Indian Immunologicals Recent Developments/Updates
Table 83. Plumbline Life Sciences Corporation Information
Table 84. Plumbline Life Sciences Description and Business Overview
Table 85. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
Table 86. Plumbline Life Sciences DNA Vaccines Product
Table 87. Plumbline Life Sciences Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. DNA Vaccines Distributors List
Table 91. DNA Vaccines Customers List
Table 92. DNA Vaccines Market Trends
Table 93. DNA Vaccines Growth Drivers
Table 94. DNA Vaccines Market Challenges
Table 95. DNA Vaccines Market Restraints
Table 96. Global DNA Vaccines Sales Forecast by Type (2022-2027) & (K Doses)
Table 97. Global DNA Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 98. Global DNA Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global DNA Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global DNA Vaccines Sales Forecast by Application (2022-2027) & (K Doses)
Table 101. Global DNA Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 102. Global DNA Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global DNA Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global DNA Vaccines Sales Forecast by Region (2022-2027) & (K Doses)
Table 105. Global DNA Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 106. Global DNA Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global DNA Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DNA Vaccines
Figure 2. Global DNA Vaccines Market Share by Type in 2020 & 2027
Figure 3. Recombinant Protein Vaccine Product Picture
Figure 4. Gene-Based Vaccine Product Picture
Figure 5. Global DNA Vaccines Market Share by Application in 2020 & 2027
Figure 6. Human
Figure 7. Animal
Figure 8. Global DNA Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global DNA Vaccines Market Size 2016-2027 (US$ Million)
Figure 10. Global DNA Vaccines Sales 2016-2027 (K Doses)
Figure 11. Global DNA Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. DNA Vaccines Sales Share by Manufacturers in 2020
Figure 13. Global DNA Vaccines Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest DNA Vaccines Players: Market Share by Revenue in 2020
Figure 15. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global DNA Vaccines Sales Market Share by Region (2016-2021)
Figure 17. Global DNA Vaccines Sales Market Share by Region in 2020
Figure 18. Global DNA Vaccines Revenue Market Share by Region (2016-2021)
Figure 19. Global DNA Vaccines Revenue Market Share by Region in 2020
Figure 20. U.S. DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E DNA Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of DNA Vaccines by Type (2016-2021)
Figure 45. Sales Market Share of DNA Vaccines by Application (2016-2021)
Figure 46. Sales Market Share of DNA Vaccines by Application in 2020
Figure 47. Revenue Share of DNA Vaccines by Application (2016-2021)
Figure 48. Revenue Share of DNA Vaccines by Application in 2020
Figure 49. Manufacturing Cost Structure of DNA Vaccines
Figure 50. Manufacturing Process Analysis of DNA Vaccines
Figure 51. DNA Vaccines Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck GSK Sanofi Zoties Elanco Boehringer-Ingelheim Indian Immunologicals Plumbline Life Sciences